We are live on ! Find out more
CNTB

Connect Biopharma Holdings
CNTB

14 hedge funds and large institutions have $4.37M invested in Connect Biopharma Holdings in 2024 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 2

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

27% more funds holding

Funds holding: 11 → 14 (+3)

3% more capital invested

Capital invested by funds: $4.23M → $4.37M (+$143K)

0.43% more ownership

Funds ownership: 5.33% → 5.76% (+0.43%)

Holders
14
Holders Change
+3
Holders Change %
+27.27%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
2
Reduced
1
Closed
2
Calls
$20K
Puts
–
Net Calls
+$20K
Net Calls Change
+$20K

Top Buyers

Rank Fund Capital Flow
1
CL
Choreo LLC
Illinois
+$185K
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$57.3K
3
CCG
Catalina Capital Group
California
+$55.1K
4
CC
Callan Capital
California
+$44K
5
GM
GeoWealth Management
Illinois
+$12.6K

Top Sellers

Rank Fund Capital Flow
1
KMWM
Keudell/Morrison Wealth Management
Oregon
-$48.2K
2
Renaissance Technologies
Renaissance Technologies
New York
-$47K
3
BlackRock
BlackRock
New York
-$2.65K
Name Holding Trade Value Shares
Change 		Change in
Stake
BCM
1
BML Capital Management
Indiana
$2.89M – – –
UOC
2
UBS O'Connor
Illinois
$705K – – –
CL
3
Choreo LLC
Illinois
$204K +$185K +160,867 New
Renaissance Technologies
4
Renaissance Technologies
New York
$186K -$47K -40,803 -23%
Royal Bank of Canada
5
Royal Bank of Canada
Ontario, Canada
$111K +$57.3K +49,800 +163%
CC
6
Callan Capital
California
$110K +$44K +38,177 +91%
CCG
7
Catalina Capital Group
California
$66.1K +$55.1K +47,867 New
Geode Capital Management
8
Geode Capital Management
Massachusetts
$38.6K – – –
Commonwealth Equity Services
9
Commonwealth Equity Services
Massachusetts
$28K – – –
GM
10
GeoWealth Management
Illinois
$15.1K +$12.6K +10,942 New
RhumbLine Advisers
11
RhumbLine Advisers
Massachusetts
$13.1K – – –
UBS Group
12
UBS Group
Switzerland
$6.53K +$5.45K +4,733 New
JP Morgan Chase
13
JP Morgan Chase
New York
$167 – – –
SS
14
SBI Securities
Japan
$8 +$7 +6 New
KMWM
15
Keudell/Morrison Wealth Management
Oregon
– -$48.2K -33,450 Closed
BlackRock
16
BlackRock
New York
– -$2.65K -1,838 Closed

CNTB Hedge Fund Activity: Q4 2024 in Review

14 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Connect Biopharma Holdings (CNTB) for Q4 2024, worth a combined $4.37M — up 3.4% from $4.23M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new CNTB positions and 2 closed out — a net gain of 3 holders — while 2 added to existing stakes and 1 trimmed.

The largest buyer was Choreo LLC, opening a new position worth an estimated $185K. The largest seller was Keudell/Morrison Wealth Management, exiting entirely with an estimated $48.2K sold.

  • 14 institutional investors held Connect Biopharma Holdings (CNTB) as of Q4 2024, up from 11 in Q3 2024.
  • Funds reported $4.37M of Connect Biopharma Holdings stock for Q4 2024, up 3.4% quarter-over-quarter.
  • 5 funds opened new Connect Biopharma Holdings positions in Q4 2024 and 2 closed out, a net change of +3 holders.
  • The largest Connect Biopharma Holdings buyer in Q4 2024 was Choreo LLC, an estimated $185K added.
  • The largest Connect Biopharma Holdings seller in Q4 2024 was Keudell/Morrison Wealth Management, an estimated $48.2K sold.

Based on aggregated 13F filings for Q4 2024.